Capricor Therapeutics, Inc. · NASDAQ:CAPR
Bergmann Anthony sold 25,000 Capricor Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 4, 2026
On May 1, 2026, Bergmann Anthony (CHIEF FINANCIAL OFFICER) sold 25,000 Capricor Therapeutics, Inc. shares at US$31.70 for US$793K under a trading plan, leaving 8,223 shares. Filed May 4, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$31.70
- Value
- US$793K
- Holding after
- 8,223 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Option exercise | 25,000 | US$3.18 | 33,223 | Direct |
| May 1, 2026 | Common Stock | Sale | 25,000 | US$31.70 | 8,223 | Direct |
Source
Related
- Capricor Therapeutics, Inc.
- Bergmann Anthony
- Capricor Therapeutics, Inc. shareholders
- Form 4 · Bergmann Anthony · Jun 29, 2026
- Form 4 · Bergmann Anthony · Jun 24, 2026
- Form 4 · Bergmann Anthony · May 19, 2026
- Form 4 · Bergmann Anthony · Apr 1, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 14, 2026
- Schedule 13G · Millennium Management LLC · Sep 14, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026